National University of Singapore clinical trials
National University of Singapore is the lead sponsor of 48 current clinical trials in our Singapore, Turkey, India, South Korea, Taiwan, China, Spain, Australia and EU (CTIS) registers. 24 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Aztreonam, Cefiderocol and Ceftazidime-avibactam. The most-studied condition is Aging.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by National University of Singapore
47 on ClinicalTrials.govRegisters list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
National University of Singapore in the EU trials register (CTIS)
1 trialAuthorised or ongoing trials in the EU Clinical Trials Information System with National University of Singapore as sponsor. Some are the same study as a ClinicalTrials.gov record above; the two registries share no common ID. Trials with a site in Ireland are listed first.
| Study | Phase | Status | Countries |
|---|---|---|---|
|
EaRly impAct theraPy with ceftazidime-avibactam via rapID diagnostics versus standard of care antibiotics and diagnostics in patients with bloodstream infection, hospital-acquired pneumonia or ventilator-associated pneumonia due to Pseudomonas aeruginosa or carbapenemase producing Enterobacterales ("RAPID")
2024-520067-13-00 · CTIS ↗ · Bacterial Infections and Mycoses
|
Phase 4 | Authorised | Italy, Greece |
Drugs in National University of Singapore trials
8 compoundsDrugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
Conditions in National University of Singapore trials
97 conditionsBy trial register
A trial with sites in more than one country appears in each of those registers.
Other sponsors in Aging
Sponsors with the most current trials registered for this condition.
Questions about National University of Singapore trials
How many clinical trials does National University of Singapore sponsor?
National University of Singapore is the lead sponsor of 47 current trials on ClinicalTrials.gov in our Singapore, Turkey, India, South Korea, Taiwan, China, Spain and Australia registers, and 1 authorised or ongoing trial in the EU register (CTIS), as of the registry sync on 15 November 2026. Completed and withdrawn studies are not counted.
Are National University of Singapore trials recruiting?
Yes. 24 of its 47 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Which drugs is National University of Singapore testing?
Its current trials name 8 drugs and biologicals as interventions. The most frequent are Aztreonam (1), Cefiderocol (1), Ceftazidime-avibactam (1), Ceftolozane-tazobactam (1) and Dulaglutide (1). The number in brackets is how many of its trials name each drug.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 15 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.